Standout Papers

Markers of Inflammation and Cardiovascular Disease 2000 2026 2008 2017 5.0k
  1. Markers of Inflammation and Cardiovascular Disease (2003)
    Thomas A. Pearson, George A. Mensah et al. Circulation
  2. C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women (2000)
    Paul M. Ridker, Charles H. Hennekens et al. New England Journal of Medicine
  3. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events (2002)
    Paul M. Ridker, Nader Rifai et al. New England Journal of Medicine
  4. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies (2015)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. BMJ
  5. Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men (2000)
    Paul M. Ridker, Nader Rifai et al. Circulation
  6. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events (2003)
    Paul M. Ridker, Julie E. Buring et al. Circulation
  7. C-Reactive Protein Levels and Outcomes after Statin Therapy (2005)
    Paul M. Ridker, Christopher P. Cannon et al. New England Journal of Medicine
  8. Protein biomarker discovery and validation: the long and uncertain path to clinical utility (2006)
    Nader Rifai, Michael A. Gillette et al. Nature Biotechnology
  9. Effect of Statin Therapy on C-Reactive Protein Levels (2001)
    Michelle A. Albert, Nader Rifai et al. JAMA
  10. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women (2007)
    Paul M. Ridker, Julie E. Buring et al. JAMA
  11. Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events (2001)
    Paul M. Ridker, Nader Rifai et al. New England Journal of Medicine
  12. Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women (2007)
    Sandeep Bansal, Julie E. Buring et al. JAMA
  13. Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein (1999)
    Paul M. Ridker, Nader Rifai et al. Circulation
  14. Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels (1998)
    Paul M. Ridker, Nader Rifai et al. Circulation
  15. Novel Risk Factors for Systemic Atherosclerosis (2001)
    Paul M. Ridker, Meir J. Stampfer et al. JAMA
  16. Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death (2006)
    Thomas J. Wang, Philimon Gona et al. New England Journal of Medicine
  17. Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women (2004)
    Jennifer K. Pai, Tobias Pischon et al. New England Journal of Medicine
  18. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies (2015)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. Radiology
  19. Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk (2004)
    Hans K. Meier-Ewert, Paul M. Ridker et al. Journal of the American College of Cardiology
  20. Prevalence of the Metabolic Syndrome in American Adolescents (2004)
    Sarah D. de Ferranti, Kimberlee Gauvreau et al. Circulation
  21. Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction (2000)
    Paul M. Ridker, Nader Rifai et al. Circulation
  22. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies (2015)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. Clinical Chemistry
  23. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk (2001)
    Teresa T. Fung, Eric B. Rimm et al. American Journal of Clinical Nutrition
  24. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction (2004)
    Esther López‐García, Matthias B. Schulze et al. American Journal of Clinical Nutrition
  25. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction (2005)
    Teresa T. Fung, Marjorie L. McCullough et al. American Journal of Clinical Nutrition
  26. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction (2005)
    Teresa T. Fung, Marjorie L. McCullough et al. American Journal of Clinical Nutrition
  27. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events (2001)
    Paul M. Ridker, Nader Rifai et al. ACC Current Journal Review
  28. Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women (2004)
    Frank B. Hu, James B. Meigs et al. Diabetes
  29. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction (2008)
    Paul M. Ridker, Nina P. Paynter et al. Circulation
  30. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy (1998)
    David A. Morrow, Nader Rifai et al. Journal of the American College of Cardiology
  31. Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women (2005)
    Paul M. Ridker, Nader Rifai et al. JAMA
  32. Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay (1999)
    Nader Rifai, Russell P. Tracy et al. Clinical Chemistry
  33. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes (2002)
    Marc S. Sabatine, David A. Morrow et al. Circulation
  34. Blood Pressure and Inflammation in Apparently Healthy Men (2001)
    Claudia U. Chae, Richard Lee et al. Hypertension
  35. Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men (2009)
    Eric L. Ding, Yiqing Song et al. New England Journal of Medicine
  36. Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease (2002)
    Aruna D. Pradhan, JoAnn E. Manson et al. JAMA
  37. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women (2024)
    Paul M. Ridker, M. Vinayaga Moorthy et al. New England Journal of Medicine

Immediate Impact

6 from Science/Nature 169 standout
Sub-graph 1 of 18

Citing Papers

Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
2025 Standout
Humoral Innate Immunity and Acute-Phase Proteins
2023 Standout
4 intermediate papers

Works of Nader Rifai being referenced

C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Nader Rifai 20990 16018 20465 20862 450 75.0k
Russell P. Tracy 19152 11301 13036 22740 663 85.4k
Charles H. Hennekens 12023 17141 12212 18066 577 83.9k
Peter W.F. Wilson 14028 29024 30320 34252 632 107.0k
Naveed Sattar 13539 22026 12405 14746 1.2k 70.7k
Børge G. Nordestgaard 10260 18383 26288 16415 936 63.7k
Yūji Matsuzawa 35983 13046 14563 16320 694 78.6k
Julie E. Buring 10461 12151 10564 15309 596 64.0k
Lewis H. Kuller 10323 15696 10797 19039 999 76.0k
Andrew S. Levey 15029 13235 17388 30240 503 121.9k
Josef Coresh 13979 16406 15647 29995 936 112.1k

All Works

Loading papers...

Rankless by CCL
2026